Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Moulard

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cytometry. Part B, Clinical Cytometry|September 3, 2015
How validated receptor occupancy flow cytometry assays can impact decisions and support drug developmentMaxime Moulard, Marie-Laure Ozoux
Thrombosis and Haemostasis|July 1, 2010
Validation of a novel ELISA-based VASP whole blood assay to measure P2Y12-ADP receptor activityPaul Barragan, Franck Paganelli, Laurence Camoin-Jau, et al.
European Journal of Pharmacology|July 9, 2014
Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptorsKatharina Hubertus, Marcel Mischnik, Jens Timmer, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 16, 2025
Recommendations for Accurate Target Expression Evaluation by Quantitative Flow CytometryTamara Lekishvili, Maxime Moulard, Sarah Jetzer, et al.
Thrombosis and Haemostasis|December 22, 2011
Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y(12) inhibitionJoseph A Jakubowski, Nicolas Bourguet, Danièle Boulay-Moine, et al.
Journal of Immunological Methods|November 28, 2012
A quantitative flow cytometric assay for determining binding characteristics of chimeric, humanized and human antibodies in whole blood: proof of principle with rituximab and ofatumumabPatrick J Engelberts, Carole Badoil, Frank J Beurskens, et al.
Journal of Virology|December 13, 2002
Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodiesPascal Poignard, Maxime Moulard, Edwin Golez, et al.
Antiviral Research|June 14, 2002
Liposomal encapsulation enhances antiviral efficacy of SPC3 against human immunodeficiency virus type-1 infection in human lymphocytesJean de Mareuil, Kamel Mabrouk, Evelyne Doria, et al.
Toxins|October 25, 2024
Antiproliferative Effects of <i>Naja anchietae</i> and <i>Naja senegalensis</i> Venom Peptides on Glioblastoma Cell LinesYasmine Boughanmi, Caroline Berenguer-Daizé, Marielle Balzano, et al.
Research and Practice in Thrombosis and Haemostasis|February 2, 2026
Selection and optimization strategy for Rap1-targeting single-domain antibodies as platelet activation markersMarie-Christine Alessi, Maxime Moulard, Daniele Boulay-Moine, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cytometry. Part B, Clinical Cytometry|September 3, 2015
How validated receptor occupancy flow cytometry assays can impact decisions and support drug developmentMaxime Moulard, Marie-Laure Ozoux
Thrombosis and Haemostasis|July 1, 2010
Validation of a novel ELISA-based VASP whole blood assay to measure P2Y12-ADP receptor activityPaul Barragan, Franck Paganelli, Laurence Camoin-Jau, et al.
European Journal of Pharmacology|July 9, 2014
Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptorsKatharina Hubertus, Marcel Mischnik, Jens Timmer, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 16, 2025
Recommendations for Accurate Target Expression Evaluation by Quantitative Flow CytometryTamara Lekishvili, Maxime Moulard, Sarah Jetzer, et al.
Thrombosis and Haemostasis|December 22, 2011
Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y(12) inhibitionJoseph A Jakubowski, Nicolas Bourguet, Danièle Boulay-Moine, et al.
Journal of Immunological Methods|November 28, 2012
A quantitative flow cytometric assay for determining binding characteristics of chimeric, humanized and human antibodies in whole blood: proof of principle with rituximab and ofatumumabPatrick J Engelberts, Carole Badoil, Frank J Beurskens, et al.
Journal of Virology|December 13, 2002
Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodiesPascal Poignard, Maxime Moulard, Edwin Golez, et al.
Antiviral Research|June 14, 2002
Liposomal encapsulation enhances antiviral efficacy of SPC3 against human immunodeficiency virus type-1 infection in human lymphocytesJean de Mareuil, Kamel Mabrouk, Evelyne Doria, et al.
Toxins|October 25, 2024
Antiproliferative Effects of <i>Naja anchietae</i> and <i>Naja senegalensis</i> Venom Peptides on Glioblastoma Cell LinesYasmine Boughanmi, Caroline Berenguer-Daizé, Marielle Balzano, et al.
Research and Practice in Thrombosis and Haemostasis|February 2, 2026
Selection and optimization strategy for Rap1-targeting single-domain antibodies as platelet activation markersMarie-Christine Alessi, Maxime Moulard, Daniele Boulay-Moine, et al.
Pageof 2